No disagreement from me.
pyroglutamate
N-terminal cyclisation, the −17 Da species, and its ambiguity with aspartimide.
Section 1
Contribution
Comments technically on records submitted by others. Annotations are signed and are not moderated for agreement.
Records submitted
0
n=0
Annotations
8
n=8
Median purity submitted
suppressed
n=0
n<3 — see individual records
Suppliers covered
0
n=0
This handle has submitted no records. Annotators comment on other people's submissions and are not required to submit.
Section 2
Annotations
Signed technical comments on records. The index does not moderate annotations for agreement with its own arithmetic, and several of these disagree with it. Where a handle has made the same point on several records, one instance is shown and the rest are reachable from the records themselves.
N-terminal cyclisation at −17 Da is the impurity most often integrated into the main peak on a short run. At 28 min it is resolved, and it is not there.
N-terminal cyclisation at −17 Da is the impurity most often integrated into the main peak on a short run. At 25 min it is resolved, and it is not there.
I would read it the same way.
N-terminal cyclisation at −17 Da is the impurity most often integrated into the main peak on a short run. At 30 min it is resolved, and it is not there.
Showing 5 distinct comments of 8 annotations by this handle.